ANKER MD, PH.D, DSC LUNDEMOSE Insider Trading $OSIP OSI PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ANKER MD, PH.D, DSC LUNDEMOSE.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ANKER MD, PH.D, DSC LUNDEMOSE. ANKER MD, PH.D, DSC LUNDEMOSE is EVP, Corp. Dev & Strategic Pln in OSI PHARMACEUTICALS INC ($OSIP) and Exec. VP & Pres. OSI Prosidion in OSI PHARMACEUTICALS INC ($OSIP).

ANKER MD, PH.D, DSC LUNDEMOSE in OSI PHARMACEUTICALS INC

Trading Symbol: OSIP
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of ANKER MD, PH.D, DSC LUNDEMOSE: EVP, Corp. Dev & Strategic Pln, Exec. VP & Pres. OSI Prosidion
Holdings: 30,623 shares
Latest Transaction: Mar 03 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ANKER MD, PH.D, DSC LUNDEMOSE in OSI PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 03 2010OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...Option ExerciseM29.7713,000387,0105,000
Mar 03 2010OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...Option ExerciseM35.1015,200533,5200
Mar 03 2010OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...SellS55.2029,2001,611,84030,62359.8 K to 30.6 K (-48.81 %)
Mar 03 2010OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...BuyM29.7713,000387,01059,82346.8 K to 59.8 K (+27.76 %)
Mar 03 2010OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...BuyM35.1015,200533,52046,82331.6 K to 46.8 K (+48.07 %)
Dec 18 2009OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...Option ExerciseA35.4020,000708,00020,000
Dec 18 2009OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...Payment of ExerciseF32.8994931,21331,62332.6 K to 31.6 K (-2.91 %)
Dec 18 2009OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...GrantA0.006,700032,57225.9 K to 32.6 K (+25.90 %)
Dec 15 2009OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...Payment of ExerciseF34.7581528,32125,87226.7 K to 25.9 K (-3.05 %)
Dec 15 2009OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCEVP, Corp. Dev & St ...Payment of ExerciseF34.7589230,99726,68727.6 K to 26.7 K (-3.23 %)
Feb 05 2009OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...Option ExerciseM29.772,00059,54018,000
Feb 05 2009OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS41.252,00082,50027,57929.6 K to 27.6 K (-6.76 %)
Feb 05 2009OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...BuyM29.772,00059,54029,57927.6 K to 29.6 K (+7.25 %)
Dec 18 2008OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...Option ExerciseA33.6248,0001,613,76048,000
Dec 18 2008OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...GrantA0.007,800027,57919.8 K to 27.6 K (+39.44 %)
Dec 16 2008OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...Payment of ExerciseF33.3981527,21319,77920.6 K to 19.8 K (-3.96 %)
Dec 16 2008OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...Payment of ExerciseF33.3989229,78420,59421.5 K to 20.6 K (-4.15 %)
Nov 12 2008OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS39.533,500138,35521,48625 K to 21.5 K (-14.01 %)
Dec 20 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS50.002,500125,00024,98627.5 K to 25 K (-9.10 %)
Dec 14 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...Option ExerciseA47.2922,0001,040,38022,000
Dec 14 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...Payment of ExerciseF47.7981538,94927,48628.3 K to 27.5 K (-2.88 %)
Dec 14 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...GrantA0.007,333028,30121 K to 28.3 K (+34.97 %)
Oct 29 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS40.002,500100,00020,96823.5 K to 21 K (-10.65 %)
Jun 15 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS37.661,00037,66023,46824.5 K to 23.5 K (-4.09 %)
May 02 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS34.801,00034,80024,46825.5 K to 24.5 K (-3.93 %)
Apr 04 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.1468522,70125,46826.2 K to 25.5 K (-2.62 %)
Apr 04 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.123009,93626,15326.5 K to 26.2 K (-1.13 %)
Apr 04 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.111549726,45326.5 K to 26.5 K (-0.06 %)
Mar 02 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.891003,38926,46826.6 K to 26.5 K (-0.38 %)
Mar 02 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.911003,39126,56826.7 K to 26.6 K (-0.37 %)
Mar 02 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.882578,70726,66826.9 K to 26.7 K (-0.95 %)
Mar 02 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.902006,78026,92527.1 K to 26.9 K (-0.74 %)
Mar 02 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.921003,39227,12527.2 K to 27.1 K (-0.37 %)
Mar 02 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS33.981003,39827,22527.3 K to 27.2 K (-0.37 %)
Mar 02 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS34.501434,93427,32527.5 K to 27.3 K (-0.52 %)
Feb 05 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS34.041003,40427,46827.6 K to 27.5 K (-0.36 %)
Feb 05 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS34.0370023,82127,56828.3 K to 27.6 K (-2.48 %)
Feb 05 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS34.02411,39528,26828.3 K to 28.3 K (-0.14 %)
Feb 05 2007OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...SellS34.001595,40628,30928.5 K to 28.3 K (-0.56 %)
Dec 15 2006OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...Option ExerciseA37.7420,000754,80020,000
Dec 15 2006OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...GrantA0.006,700028,46821.8 K to 28.5 K (+30.78 %)
Jul 18 2006OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...GrantA0.006,700021,76815.1 K to 21.8 K (+44.47 %)
Jun 15 2006OSIPOSI PHARMACEUTICAL ...LUNDEMOSE ANKER MD, PH.D, DSCExec. VP & Pres. OS ...Option ExerciseA29.7720,000595,40020,000

Page:   1